ICAM1 and malaria: Early studies found that hydroxyurea raised concentrations of ICAM-1 in an in vitro model of SCA [13], raising concern that this could lead to an increased risk of parasite binding in children with SCA and therefore to increased sequestration and complications (including death) from malaria.